Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials

Historically, subject matter experts and healthcare professionals have played a pivotal role in driving oncology clinical trials. Although patients have been key participants, their deliberate and active contribution to the design and decision-making process has been limited. This scoping review aim...

Full description

Saved in:
Bibliographic Details
Published in:Current oncology (Toronto) 2023-09, Vol.30 (9), p.8310-8327
Main Authors: Farah, Eliya, Kenney, Matthew, Kica, Anris, Haddad, Paul, Stewart, David J, Bradford, John-Peter
Format: Article
Language:English
Subjects:
Cancer patients
Clinical trials
design oncology clinical trial
Evidence-based medicine
evidence-based patient engagement
Medical personnel
Medical research
Medicine, Experimental
oncology clinical trial
patient centricity
Systematic Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Historically, subject matter experts and healthcare professionals have played a pivotal role in driving oncology clinical trials. Although patients have been key participants, their deliberate and active contribution to the design and decision-making process has been limited. This scoping review aimed to examine the existing literature to scope the extent of active patient engagement in the design of oncology clinical trials and its corresponding influence on trial outcomes. We conducted a systematic search using two databases, namely MEDLINE (Ovid) and EMBASE, to identify relevant studies exploring patient engagement in cancer-related clinical research design. We identified seven studies that met the eligibility criteria. The studies highlighted the benefits of active patient involvement, such as improved recruitment strategies, and the attainment of more patient-centered trial outcomes. The influence of patient involvement varied from tangible developments like patient-friendly resources to indirect impacts like improved patient experiences and potentially higher adherence to trial intervention. The future of clinical trials should prioritize patients’ values and perspectives, with regulatory bodies fostering these practices through clear guidelines. As the concept of patient centricity takes root in oncology research, the involvement of patients should evolve beyond mere participation.
ISSN:1718-7729
1198-0052
1718-7729
DOI:10.3390/curroncol30090603